James Landreneau

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro”.

Evaluation of CRISPR/Cas9 mediated TGIF gene editing to inhibit corneal fibrosis in vitro

Experimental Eye Research(2022)10.1016/j.exer.2022.109113

N/A

0DataRank · unranked

22 citations

Nishant R. Sinha, Duraisamy Kempuraj, Praveen Kumar Balne, James Landreneau, Ankit Juneja +3 more

Toxicological effects of ocular acrolein exposure to eyelids in rabbits in vivo

Experimental Eye Research(2023)10.1016/j.exer.2023.109575

N/A

0DataRank · unranked

3 citations

Lynn M. Martin, Eric Zhang, Prashant R. Sinha, James Landreneau, Nishant R. Sinha +3 more

Tissue-targeted and localized AAV5-DCN and AAV5-PEDF combination gene therapy abrogates corneal fibrosis and concurrent neovascularization in rabbit eyes in vivo

The Ocular Surface(2024)10.1016/j.jtos.2024.01.001

N/A

0DataRank · unranked

22 citations

Suneel Gupta, Rajnish Kumar, Nishant R. Sinha, James Landreneau, Prashant R. Sinha +4 more